PARTNERED

Polymeric Bile Acid Formulations for Targeted Delivery

• A new class of polymer biomaterials (PUDCA) that are selectively taken up and retained in the pancreatic, hepatic and colon microenvironment.
• Formulated as orally administered, safe and biodegradable nanoparticles.
• Unique properties: encapsulates drugs and/or agents, pH-responsive, enables sustained release.
• Indications: targeted delivery of drugs and tracking/imaging agents to sites of pancreatic, hepatic and colonic inflammation. For therapy and diagnostic uses
• Innovator: Tarek Fahmy, Ph.D.
• IP status: WO2017041053A1, and related Nat’l phase in US, EP, CA, CN, AU
• Publications: Unpublished work